Article Information
History
- September 22, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Kristian Larsen1,2,
- Ulrich Lindberg3,
- Brice Ozenne1,4,
- Drummond E. McCulloch1,2,
- Sophia Armand1,5,
- Martin K. Madsen1,6,
- Annette Johansen1,
- Dea S. Stenbæk1,5,
- Gitte M. Knudsen1,2 and
- Patrick M. Fisher1,7,*
- 1Neurobiology Research Unit and NeuroPharm, Rigshospitalet, Copenhagen, Denmark
- 2Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
- 3Functional Imaging Unit, Department of Clinical Physiology and Nuclear Medicine, Rigshospitalet, Copenhagen, Denmark
- 4Department of Public Health, Section of Biostatistics, University of Copenhagen, Copenhagen, Denmark
- 5Department of Psychology, University of Copenhagen, Copenhagen, Denmark
- 6Department of Psychiatry Svendborg, Denmark
- 7Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark
- ↵*Corresponding author; email: patrick{at}nru.dk
Posted September 22, 2024.
Acute psilocybin and ketanserin effects on cerebral blood flow: 5-HT2AR neuromodulation in healthy humans
